Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2025-12-25 @ 4:24 PM
NCT ID:
NCT00077857
Group ID:
EG000
Title:
1250 mg/m^2 Capecitabine + Docetaxel
Description:
1250 mg/m\^2 capecitabine (Xeloda®) orally twice a day on days 1 to 14 of each 3 week cycle, in combination with docetaxel (Taxotere®) 75 mg/m\^2 intravenous on day 1 of each 3 week cycle.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
41
Serious Number At Risk:
217
Other Number Affected:
192
Other Number At Risk:
217
Study:
NCT00077857
Results Section:
NCT00077857
Adverse Events Module:
NCT00077857